<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03355040</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL17_0261</org_study_id>
    <nct_id>NCT03355040</nct_id>
  </id_info>
  <brief_title>Induction of Labour for LGA fœtus in Women Without Insulin-treated Diabetes.</brief_title>
  <official_title>Induction of Labour for LGA fœtus in Women Without Insulin-treated Diabetes.. Application of DAME Study in Montpellier University Hospital.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A french study published in 2015 (DAME) showed a decrease of shoulder dystocia and an
      increase of spontaneous vaginal delivery when the non insulin-treated diabetes patients with
      large-for-date fetus were induced.

      This new protocole was introduced in Montpellier University Hospital delivery room.

      The aim of this study is to evaluate the protocole in Montpellier hospital and to compare our
      results with the DAME results.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Currently, large for date fœtus need an induction of labour just if the mother is an insulin
      diabetic.

      The DAME's protocol included the large for date feotus witch have a estimate weight &gt;3500g at
      36 GA, &gt;3700g at 37 GA, &gt;3900g at 38 GA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2016</start_date>
  <completion_date type="Actual">January 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of shoulder dystocia</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>number of shoulder dystocia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of Clavicle fracture</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>number of Clavicle fracture</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of Brachial plexus injury</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>number of Brachial plexus injury</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of Intracranial heamorrhage</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>number of Intracranial heamorrhage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of Neonatal death</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>number of Neonatal death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Cord blood pH&lt; 7,10 for the newborn</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>Number of Cord blood pH&lt; 7,10 for the newborn</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of apgar &lt; 7 at 5 min for the newborn</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>Number of apgar &lt; 7 at 5 min for the newborn</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of admission to neonatal intensive care unit for the newborn</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>Number of admission to neonatal intensive care unit for the newborn</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of highest bilirubin concentration for the newborn</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>Number of highest bilirubin concentration for the newborn</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Caesarean for the patient</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>Number of Caesarean for the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Forceps or vacuum for the patient</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>Number of Forceps or vacuum for the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Haemorrage and blood transfusion for the patient</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>Number of Haemorrage and blood transfusion for the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Anal sphincter tear for the patient</measure>
    <time_frame>1 day (after delivery)</time_frame>
    <description>Number of Anal sphincter tear for the patient</description>
  </secondary_outcome>
  <enrollment type="Actual">150</enrollment>
  <condition>Macrosomia</condition>
  <condition>Induction of Labour</condition>
  <condition>Non-insulin-dependent Diabetes</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>induction of labour</intervention_name>
    <description>induction of labour</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant patients non diabetic or diabetic without insulin-treatment with large for date
        fœtus.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        Age &gt;18 years old Single pregnancy Cephalic presentation no contraindications to planned
        vaginal delivery no fœtal pathology

        Large-for-date foetus (estimated weight &gt; 95%) :

          -  Clinically suspeted or estilated weight &gt;90% at the 3 trimester ultrasound

          -  Estimated fœtal weight :

        &gt; 3500g at 36 GA &gt; 3700g at 37 GA &gt; 3900g at 38 GA

        Exclusion criteria:

        Age &lt;18 yeaurs old contraindications to vaginal delivery insulin-trated diabetics or
        imbalance diabetics. neonatal trauma or shoulder dystocia, severe urinary or faecal
        incontinence.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>florent FUCHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>October 12, 2017</study_first_submitted>
  <study_first_submitted_qc>November 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2017</study_first_posted>
  <last_update_submitted>April 17, 2019</last_update_submitted>
  <last_update_submitted_qc>April 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>shoulder dystocia</keyword>
  <keyword>maternal and neonatal morbidity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

